Mar 27, 2008
Medicare to Now Cover INR Self Testing for Patients on Anticoagulants for Chronic Atrial Fibrillation and Venous Thromboembolism |
| |
SAN JOSE, Calif., March 27, 2008 - The announcement this past week from the Centers for Medicare & Medicaid Services (CMS) that Medicare coverage for at-home blood testing of prothrombin time (PT)/International Normalized Ratio (INR) will be expanded is welcome news to the millions of patients who take anticoagulants daily a...
|
Oct 18, 2007
HemoSense Receives Patent Infringement Notification from Beckman Coulter |
| |
SAN JOSE, Calif., Oct 18, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced that Beckman Coulter, Inc. ("Beckman") has filed a complaint in the United States District Court for the Northern District of California, alleging that HemoSense is infringing a patent held by Beckman, relating to the HemoSense INRatio(R) system. Beckman is...
|
Oct 2, 2007
Inverness Medical Innovations and HemoSense Corporation Announce Expiration of Hart-Scott-Rodino Waiting Period |
| |
WALTHAM, Mass., Oct 02, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Inverness Medical Innovations, Inc. (Amex: IMA) and HemoSense Corporation (Amex: HEM) today announced that the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to Inverness' proposed acquisition of HemoSense has expired....
|
Aug 7, 2007
CORRECTING and REPLACING HemoSense Fiscal Third Quarter Revenue Increases 101% |
| |
SAN JOSE, Calif., Aug 07, 2007 (BUSINESS WIRE) -- The Inventories, net for June 30, 2007 in the Balance Sheet should read 5,076 (sted 5,026). The corrected Balance Sheet is included in the corrected version of the release below.
The corrected release reads:
HEMOSENSE FISCAL THIRD QUARTER REVENUE INCREASES 101%
Fiscal 2007 Revenue Guidan...
|
Aug 7, 2007
HemoSense Fiscal Third Quarter Revenue Increases 101% |
| |
SAN JOSE, Calif., Aug 07, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX: HEM) - a point of care diagnostic healthcare company that has developed, manufactures and sells easy-to-use, handheld blood coagulation monitoring systems for use by patients and healthcare professionals in the management of warfarin medication - today reported financial resul...
|
Aug 6, 2007
Inverness Medical Innovations to Acquire Hemosense, Inc. |
| |
WALTHAM, Mass., Aug 06, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Inverness Medical Innovations, Inc. (Amex: IMA) and HemoSense, Inc. (Amex: HEM) today announced that they have entered into a definitive agreement for Inverness to acquire Hemosense in an all stock deal. Each holder of a share of HemoSense common stock will receive 0.274...
|
Jul 30, 2007
HemoSense to Hold Fiscal 2007 Third Quarter Financial Results Conference Call on August 7 |
| |
SAN JOSE, Calif., Jul 30, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced that it will release financial results for the three and nine months ended June 30, 2007 after market close on Tuesday, August 7, 2007. HemoSense management will host an investment community conference call beginning at 4:30 p.m. Eastern time (1:30 p.m. Pac...
|
May 24, 2007
HemoSense to Present at the Friedman Billings Ramsey Growth Conference |
| |
SAN JOSE, Calif., May 24, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced that Jim Merselis, President and CEO, will make an investment community presentation at the 2007 FBR Growth Conference on Thursday, May 31, at 2:20 p.m. Eastern time (11:20 a.m. Pacific time). The conference is being held at the Grand Hyatt Hotel in New Yor...
|
May 15, 2007
HemoSense to Supply LabCorp(R) with INRatio System |
| |
SAN JOSE, Calif., May 15, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced that it has signed an agreement with Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) to supply the HemoSense portable INRatio(R) PT/INR monitoring system to identified LabCorp laboratories. The INRatio system will also be made available...
|
May 4, 2007
HemoSense and ZyCare Partner with Pima Heart to Utilize Web-Based Warfarin Patient Management System for INRatio |
| |
SAN JOSE, Calif. & CHAPEL HILL, N.C., May 04, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) and ZyCare, Inc. today announced that Pima Heart, a cardiology practice that provides medical and surgical services in southern Arizona, will use ZyCare's CoagCare(R) software management system to remotely manage Pima Heart patients who wish to use Hemo...
|
May 1, 2007
HemoSense Second Quarter Revenue Increases 98% |
| |
SAN JOSE, Calif., May 01, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) - a point of care diagnostic healthcare company that develops, manufactures and sells easy-to-use, handheld blood coagulation monitoring systems for use by patients and healthcare professionals in the management of warfarin medication - today reported financial results for...
|
Apr 24, 2007
HemoSense to Hold Fiscal 2007 Second Quarter Financial Results Conference Call on May 1 |
| |
SAN JOSE, Calif., Apr 24, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced that it will release financial results for the fiscal 2007 second quarter ended March 31, 2007 after market close on Tuesday, May 1, 2007. HemoSense management will host an investment community conference call beginning at 4:30 p.m. Eastern time (1:30 p.m. ...
|
Apr 10, 2007
HemoSense Satisfies FDA Concerns and Completes ISO Audit |
| |
SAN JOSE, Calif., Apr 10, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced it has received acknowledgement from the U.S. Food and Drug Administration (FDA) that the Company has satisfactorily addressed the concerns about its quality management system detailed in a Warning Letter from the FDA in November 2006. The Company also anno...
|
Mar 8, 2007
HemoSense Signs Agreement for INRatio Distribution in Canada |
| |
SAN JOSE, Calif., Mar 08, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced that it has signed an agreement with ManthaMed, a Canadian provider of health screening, monitoring and diagnostic testing technologies, to market and distribute HemoSense's portable INRatio(R) PT/INR monitoring system for patient self-testing and healthcar...
|
Feb 13, 2007
HemoSense to Present at the Roth Capital Partners 19th Annual Stock Conference |
| |
SAN JOSE, Calif., Feb 13, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced that Jim Merselis, President and CEO, will make an investment community presentation at the Roth Capital Partners 19th Annual Stock Conference on Wednesday, February 21 at 11:00 a.m. Pacific time (2:00 p.m. Eastern time). The conference is being held at the...
|
Feb 9, 2007
HemoSense Names Conan Li to VP of Research & Development |
| |
SAN JOSE, Calif., Feb 09, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced that Conan Li, Ph.D., 55, has joined the Company as vice president, research and development. Dr. Li replaces Mags McInerney, Ph.D., who resigned in November 2006 to pursue other business opportunities.
"Conan brings to HemoSense more than 25 years of i...
|
Feb 1, 2007
HemoSense First Quarter Revenue Increases 96% |
| |
SAN JOSE, Calif., Feb 01, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) - a medical device company that develops, manufactures and sells easy-to-use, handheld blood coagulation monitoring systems for use by patients and healthcare professionals in the management of warfarin medication - today reported financial results for the first quarter of...
|
Jan 30, 2007
HemoSense's INRAtio System Receives Marketing Approval in Canada |
| |
SAN JOSE, Calif., Jan 30, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced that it has received medical device licenses from Health Canada to market its INRatio(R) PT/INR monitoring system for point-of-care and patient self testing in Canada. HemoSense expects to formalize distribution relationships during the current fiscal quart...
|
Jan 26, 2007
HemoSense to Hold Fiscal First Quarter 2007 Financial Results Conference Call on February 1 |
| |
SAN JOSE, Calif., Jan 26, 2007 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced that it will release financial results for the fiscal first quarter ended December 31, 2006 after market close on Thursday, February 1, 2007. HemoSense management will host an investment community conference call beginning at 4:30 p.m. Eastern Time (1:30 p....
|
Dec 12, 2006
HemoSense Raises $7 Million in Private Placement |
| |
SAN JOSE, Calif., Dec 12, 2006 (BUSINESS WIRE) -- HemoSense, Inc. (AMEX:HEM) today announced that it has closed a private placement in which it sold approximately 1.77 million shares of its common stock at a price of $3.95 per share, raising approximately $7.0 million in gross proceeds from a single institutional investor, New Enterprise Associates...
|
|
|
